Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma.

Documenti analoghi

• Preliminary report of the use of everolimus in a patient with progressive medullary thyroid carcinoma
  di: Druce, M, et al.
  Pubblicazione: (2012)
• Preliminary Report of the Use of Everolimus in a Patient with Progressive Medullary Thyroid Carcinoma
  di: Druce, M, et al.
  Pubblicazione: (2010)
• The rapamycin-derivative RAD001 (everolimus) inhibits cell viability and interacts with the Akt-mTOR-p70S6K pathway in human medullary thyroid carcinoma cells.
  di: Grozinsky-Glasberg, S, et al.
  Pubblicazione: (2010)
• The Rapamycin Derivative RAD001 (Everolimus) Inhibits Cell Proliferation and Interacts with the Akt-mTOR-p70S6K Pathway in Human Medullary Thyroid Carcinoma Cells
  di: Grozinsky-Glasberg, S, et al.
  Pubblicazione: (2009)
• IGF-1 influences Everolimus activity in medullary thyroid carcinoma
  di: Erica eGentilin, et al.
  Pubblicazione: (2015-05-01)